Aluminum chloride phthalocyanine in MCF-7: Rationally accounting for state of aggregation of photosensitizers inside cells
Source abstract
Abstract
Abstract Current limited understanding of the intracellular self-aggregation process of several photosensitizers is one of the obstacles in the progress of Photodynamic Therapy (PDT) as a clinically viable option to photomodulate the biological responses. This is further intensified by the higher in vitro experimental complexity as compared to the experiments carried out in simple solution. This study describes the monomer(photoactive)/aggregate(non-active) equilibrium of aluminum chloride phthalocyanine (AlClPc) within the human breast adenocarcinoma cell line, MCF-7. Steady-state fluorescence and fluorescence lifetime imaging microscopy demonstrated that there was an upper limit of the amount of monomeric AlClPc inside cells, which might be influenced by the high water content inside the biological tissue. In this process, high AlClPc concentrations triggered the aggregation process while lowering its monomeric active form. The monomer/aggregates equilibrium can be modulated even inside cell typically through cell replication process, which decreases the AlClPc content inside each cellular unit. The results underline the need for new strategies in order to enhance the AlClPc monomerization within cells, especially in key organelles for PDT including mitochondria and lysosome membrane. This study demonstrates a rational approach for the study of the state of aggregation of photosensitizers inside cells, which is a critical issue to be considered for PDT efficacy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Photodynamic therapy of cancer: an update
2. Highly efficient photodynamic therapy colloidal system based on chloroaluminum phthalocyanine/pluronic micelles10.1016/j.ejpb.2016.03.028 ↗
3. Spectroscopic analysis of aluminum chloride phthalocyanine in binary water/ethanol systems for the design of a new drug delivery system for photodynamic therapy cancer treatment10.1016/j.saa.2015.08.027 ↗
4. Photophysical and photochemical properties of zinc and aluminum phthalocyanines in the presence of magnetic fluid10.1016/j.jphotochem.2006.12.013 ↗
5. Aluminum-chloride-phthalocyanine encapsulated in liposomes: activity against naturally occurring dog breast cancer cells10.1166/jbn.2012.1378 ↗
6. Application of aluminum chloride phthalocyanine-loaded solid lipid nanoparticles for photodynamic inactivation of melanoma cells10.1016/j.ijpharm.2017.01.004 ↗
7. Photodynamic therapy with aluminum-chloro-phtalocyanine induces necrosis and vascular damage in mice tongue tumors10.1016/j.jphotobiol.2008.11.003 ↗
8. Photodynamic therapy using ultradeformable liposomes loaded with chlorine aluminum phthalocyanine against L.(V.) braziliensis experimental models10.1016/j.exppara.2018.09.016 ↗
9. Physicochemical and photodynamic antimicrobial chemotherapy activity of morpholine-substituted phthalocyanines: effect of point of substitution and central metal10.1016/j.jphotochem.2019.01.025 ↗
10. Synthesis, spectroscopic properties, thermal properties and aggregation behaviors of macrogol-substituted phthalocyanines10.1016/j.molstruc.2019.03.071 ↗
11. Dissociation of zinc phthalocyanine aggregation on bacterial surface is key for photodynamic antimicrobial effect10.1142/S1088424618500888 ↗
12. Evidence for intracellular aggregation of hypericin and the impact on its photocytotoxicity in PAM 212 murine keratinocytes¶10.1111/j.1751-1097.2004.tb00111.x ↗
13. Theoretical and experimental studies concerning monomer/aggregates equilibrium of zinc phthalocyanine for future photodynamic action10.1016/j.saa.2019.02.086 ↗
14. New water soluble cationic zinc phthalocyanines as potential for photodynamic therapy of cancer10.1016/j.jorganchem.2013.08.025 ↗
15. Formulation of aluminum chloride phthalocyanine in Pluronic™ P‐123 and F‐127 block copolymer micelles: photophysical properties and photodynamic inactivation of microorganisms10.1111/php.12421 ↗
16. Aluminum–phthalocyanine chloride associated to poly (methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy10.2147/IJN.S57420 ↗
17. Photophysical studies of zinc phthalocyanine and chloroaluminum phthalocyanine incorporated into liposomes in the presence of additives10.1590/S0100-879X2004000200016 ↗
18. Lipid vesicles loading aluminum phthalocyanine chloride: formulation properties and disaggregation upon intracellular delivery10.1016/j.jphotobiol.2016.03.050 ↗
19. Petrasek · 1999 · 285
20. Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells10.1186/s12951-015-0095-3 ↗
21. In vitro phototoxicity of ultradeformable liposomes containing chloroaluminum phthalocyanine against New World Leishmania species10.1016/j.jphotobiol.2012.09.018 ↗
22. Adipogenic differentiation of murine bone marrow mesenchymal stem cells induced by visible light via photo-induced biomodulation10.1016/j.pdpdt.2018.11.013 ↗
23. Validated spectrophotometric and spectrofluorimetric methods for determination of chloroaluminum phthalocyanine in nanocarriers
24. Unveiling the hydrogen bonding network of intracellular water by fluorescence lifetime imaging microscopy10.1021/acs.jpcc.8b12439 ↗
25. Water is an active matrix of life for cell and molecular biology10.1073/pnas.1703781114 ↗
26. Cell death pathways in photodynamic therapy of cancer10.3390/cancers3022516 ↗
27. Action spectra of phthalocyanines with respect to photosensitization of cells10.1111/j.1751-1097.1992.tb02144.x ↗
28. Classification of cell death: recommendations of the nomenclature committee on cell death 200910.1038/cdd.2008.150 ↗
29. Targeting apoptotic and autophagic pathways for cancer therapeutics10.1016/j.canlet.2010.10.001 ↗
30. Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy10.4161/auto.6.2.11077 ↗
31. Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity responses following photodynamic therapy10.1039/c4pp00466c ↗
32. Photodynamic therapy mediated by liposomal chloroaluminum-phthalocyanine induces necrosis in oral cancer cells10.1166/jbt.2013.1070 ↗
33. Parallel damage in mitochondria and lysosomes is an efficient way to photoinduce cell death10.1080/15548627.2018.1515609 ↗
34. Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low-dose chemotherapeutic agents on gastric cancer cells
35. Effective phthalocyanines mediated photodynamic therapy with doxorubicin or methotrexate combination therapy at sub-micromolar concentrations in vitro10.1016/j.pdpdt.2018.02.010 ↗
36. Comparative in vitro study of photodynamic activity of hypericin and hypericinates in MCF-7 cells10.1016/j.jphotobiol.2017.08.025 ↗
37. Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells10.1038/sj.bjc.6600664 ↗
38. Evaluation of a chloroaluminium phthalocyanine-loaded magnetic nanoemulsion as a drug delivery device to treat glioblastoma using hyperthermia and photodynamic therapy10.1039/C6RA26105A ↗
39. Photodynamic process induced by chloro-aluminum phthalocyanine nanoemulsion in glioblastoma10.1016/j.pdpdt.2017.05.003 ↗
40. Phthalocyanine fluorescence at high concentration: dimers or reabsorption effect?10.1111/j.1751-1097.1995.tb08619.x ↗